Zainab Muhammad1, Mahboob Alam2, Nurul Huda Abd Kadir1*
1. Faculty of Science and Marine Environment, Universiti Malaysia Terengganu, 21030 Kuala Nerus, Terengganu, Malaysia
2. Department of Safety Engineering, Dongguk University, 123 Dongdae-ro, Gyeongbuk, 780714, South Korea
*Corresponding author: Nurul Huda Abd Kadir.
ABSTRACT
INTRODUCTION: Cancer remains a significant global health challenge, responsible for one in every six fatalities worldwide. Despite cytotoxic agents like cisplatin being extensively utilised, their effectiveness is frequently constrained by dose-dependent toxicity and non-specific dispersion. To address these constraints, nanocarriers are being actively investigated to enhance drug delivery and therapeutic efficacy. Nonetheless, research on the synergistic application of silver nanoparticles (AgNPs) with cisplatin in MCF-7 cells is scarce.
OBJECTIVE(S): This study evaluated the potential of Chromolaena odorata-synthesised AgNPs to augment the interaction of cisplatin with essential biomolecules, specifically calf thymus DNA (ctDNA), bovine serum albumin (BSA), and human serum albumin (HSA), for improving efficacy and synergistic cytotoxicity in MCF-7 breast cancer cells.
MATERIALS & METHODS: Binding interactions were analysed by fluorescence spectroscopy and molecular docking, whereas cytotoxicity was evaluated using the MTT assay.
RESULTS: Spectroscopic investigation demonstrated that AgNPs, both independently and in conjunction with cisplatin, established stable complexes with ctDNA, BSA, and HSA, exhibiting increased binding affinity in the combination group, especially with HSA, indicating enhanced drug delivery. The amalgamation of AgNPs and cisplatin elicited more pronounced conformational alterations in DNA and proteins compared to each agent alone, signifying enhanced binding interactions. Molecular docking corroborated this finding, revealing that the combined system had the highest binding affinity (E-total = −254 kcal/mol), in contrast to AgNPs (−223.35 kcal/mol) and cisplatin alone (−112.30 kcal/mol). Cytotoxicity studies indicated that AgNPs had modest activity independently, but, in conjunction with cisplatin, they revealed a significant synergistic impact, with an IC₅₀ of 33.05 µg/mL AgNPs and 7.5 µg/mL cisplatin after 48 hours.
CONCLUSION: Chromolaena odorata-synthesised AgNPs markedly augment cisplatin's affinity for critical biomolecules, enhance drug transport efficacy, and amplify lethal effects on MCF-7 cells. This study emphasises the potential of nanoparticle-based approaches for enhanced and tailored cancer treatments.
KEYWORDS: Silver Nanoparticles, Cisplatin, Drug Delivery


